The meeting with NCI will be key, at least to me.Will give us an idea of how many resources that the NCI will send our way, over the next little while.Sloan is also a bonus, though I have not heard what their plans are. We are well into november so news shouldnt be that far off, though I believe too many here are news centric. Im more interested now in the possibilities for licensing, and taking this to another level. I know someone posted in the past in regards to potential costs for human trials. Its an interesting number, not sure what may come of it, but I sure would like to see someone move this towards clinicals.
Just my thoughts.